Sarowitz Steven I

Angel Studios director Sarowitz acquires over 321K shares in substantial open-market purchase as stock trades sharply below 52-week high.

Director Steven Sarowitz purchased over 321,000 shares at a single price point, representing a massive increase to his ownership position. The purchase stands out because it comes while the stock is trading substantially below its recent highs and Sarowitz has a notable insider history—his twenty prior transactions were all sales, and those sales were consistently well-timed against subsequent price declines. This flip from an exclusive track record of selling to a significant buy deserves attention. However, Angel Studios is currently unprofitable and burning cash, even as revenues have grown substantially. Sarowitz is buying into a company with deteriorating financial fundamentals, which blunts the signal that a director's purchase might otherwise carry. The shift from systematic selling to accumulation is unusual and worth monitoring closely, but the underlying business condition—negative earnings and significant losses—introduces real risk to the thesis.

Director Sarowitz sold 14,123 shares across 2 transactions for $2,830,566.48, reducing holdings 5.3% from 265.2K to 251.1K shares.

Steven I Sarowitz, Director at Paylocity, executed 2 separate sales totaling 14,123 shares for $2,830,566.48 on 2025-05-20 and 2025-05-21 at a blended average price of $200.42. The company reported strong fundamentals with revenue of $454,548,000.00 and net income of $91,483,000.00 in the latest quarter, alongside 19.4% annual revenue growth. The sales occurred in proximity to each other and reduced Sarowitz's stake by 5.3%, from 265,191 shares to 251,068 shares. Current price of $196.91 is 9.6% below the 52-week high of $217.86, and the 30-day change shows +7.6% momentum despite the longer 90-day decline of -3.9%.

Director Sarowitz sells 125,701 shares for $25,235,429.67 via pre-arranged 10b5-1 plan

Director Steven I Sarowitz executed 4 separate sales totaling 125,701 shares for $25,235,429.67 on 2025-05-16 and 2025-05-19, reducing his holdings from 390,892 shares to 265,191 shares. The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2024-12-17, meaning the sales were scheduled, not discretionary. The blended average sale price was $200.76. With 32.2% of his pre-transaction holdings liquidated through scheduled execution, the filing reflects a reduction in equity concentration rather than a discretionary trading decision or immediate signal about stock valuation or company fundamentals.

Director Sarowitz sold 11,108 PCTY shares at $200.32; holds 390,892 post-trade amid stock up 9.4% in 30d.

Steven I Sarowitz sold 11,108 shares for $2,225,154.56 on 2025-05-14 at $200.32, reducing his stake by 2.8% to 390,892 shares. The sale occurred within a recent run-up—PCTY has gained 9.4% in the 30-day period preceding this trade and stands at $201.04, just below the transaction price. The director's cross-ticker track record shows a 100.00% well-timed sell rate with an average 90-day return of -6.5% across 20 prior sales, suggesting a pattern of selling before declines; however, his five prior trades at PCTY itself are all too recent (conducted 2025-05-12 through 2025-05-16) to have measurable outcomes. With a P/E of 48.80 and revenue growth of 19.4% year-over-year, PCTY trades at a premium valuation, but this single sale—a routine portfolio adjustment for a 390K-share holder—does not constitute material evidence of concern at the company fundamentals level.

Director Steven I Sarowitz sold 18,000 shares of PCTY for $3,611,837.20 across 3 transactions at $200.54–$201.19 (5/12–5/13).

Steven I Sarowitz, a Director, executed 3 separate sales totaling 18,000 shares for $3,611,837.20 at an average price of $200.66, reducing his holdings from 420,000 to 402,000 shares (-4.3%). The sales occurred at prices near the top of the 52-week range ($131.85–$217.86), with current price at $199.47 suggesting the insider sold close to recent highs. His cross-ticker track record shows a 100.00% well-timed rate across 20 prior sells with an average 90-day return of -6.7%, but at PCTY specifically, all 5 prior measurable trades show negative 30-day returns (-3.4% to -5.9%), with no 90-day outcomes yet available for prior PCTY trades. The timing of this sale relative to the stock's +6.4% 30-day gain and proximity to the 52-week high warrants observation of near-term price action.

Director Sarowitz sells 26,252 shares for $5.1M in 3 transactions via scheduled 10b5-1 plan

Steven I. Sarowitz, Director of Paylocity Holding Corp, executed 3 separate sales totaling 26,252 shares for $5,116,789.73 at a blended average price of $194.91 on 2025-03-24. This sale reduces his holdings from 446,252 shares to 420,000 shares, a decline of 5.9%. The transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2024-12-17, indicating the sale was scheduled rather than discretionary. As a routine programmed execution of an existing plan, this filing does not signal a spontaneous shift in insider positioning, but rather reflects the continuation of a predetermined disposition strategy established months prior.

Director Steven Sarowitz sold 47,443 shares for $9,067,321.70 via scheduled 10b5-1 plan adopted 2024-12-17

Director Steven Sarowitz executed 5 separate sales totaling 47,443 shares for $9,067,321.70 on 2025-03-20 and 2025-03-21, at prices between $190.44 and $192.16 per share. This transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2024-12-17, making it a scheduled sale rather than a discretionary trade. Post-transaction holdings stand at 446,252 shares, representing a 9.6% reduction from his prior position of 493,695 shares. As a scheduled transaction, this sale reflects a pre-determined disposition plan established months in advance and carries no timing signal regarding current valuation or near-term prospects.

Director Sarowitz sells 26,305 shares for $5,028,948.35 under pre-arranged 10b5-1 plan

Sarowitz Steven I, a Director at Paylocity Holding Corp, executed 4 separate sales totaling 26,305 shares (26.3K shares) for $5,028,948.35 ($5.0M) at blended average price of $191.18 across March 18-19, 2025. His holdings decreased from 520,000 shares to 493,695 shares, representing a -5.1% reduction in stake. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2024-12-17, indicating scheduled rather than discretionary execution. The structured, scheduled nature of the sales under a pre-adopted plan means this is routine portfolio management activity rather than a discretionary signal of conviction or concern.

Director Sarowitz sold 11,473 shares at blended $203.37 on 2024-12-17 for $2.3M, retaining 8.34M shares post-transaction.

Sarowitz sold 11,473 shares across 5 transactions on 2024-12-17 for a total of $2,333,312.49 at prices ranging from $201.20 to $205.00, representing a -0.1% net change to his holdings. This sale occurred while the stock traded near its 52-week high of $213.79, with current price at $196.20 reflecting an -8.2% pullback from peak. The director maintains substantial continued ownership of 8,344,545 shares and the modest reduction (0.1% of holdings) appears proportional to his existing position. Notably, Sarowitz executed multiple sales the prior day (2024-12-16, per SAME-TICKER HISTORY), suggesting a deliberate liquidation sequence rather than a one-time event, though recent timing outcomes at this ticker are not yet measurable due to the recency of transactions.

Director Sarowitz sold 9,515 shares at average $202.55 for $1.9M on 2024-12-16

Director Steven I Sarowitz executed 4 separate sales totaling 9,515 shares for $1,927,232.15 on 2024-12-16, reducing his holdings from 8,365,533 to 8,356,018 shares (-0.1%). The transaction occurred at prices ranging from $200.48 to $203.67, near the company's 52-week high of $213.79 and above the current price of $194.40. Paylocity trades at a P/E of 48.84 with recent quarterly revenue of $362,956,000.00 and annual revenue growth of +19.4%, reflecting a high-growth profile. The sale represents a modest reduction in holdings and follows 5 recent sales at the same ticker (2024-12-17), though prior sale-timing outcomes at this ticker are not yet measurable.